Analytical Data
-
Gene name
CAPN7
- Application
-
Alternative Names
PalBH; Calpain Like Protease; Homolog Of Aspergillus Nidulans PALB
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y6W3
-
Expression Region
Met1~Pro157
-
Molecular Weight
25kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CAPN7, a member of the calpain family of cysteine proteases, plays a significant role in various cellular processes, including cell migration, differentiation, and apoptosis. Research has shown that CAPN7 is involved in muscle development and repair, making it a potential biomarker for muscle-related diseases. Unlike other calpains, CAPN7 exhibits distinct tissue expression patterns and regulatory mechanisms, which have sparked interest in its functional characterization. Recent studies have suggested that CAPN7 may influence cellular signaling pathways and contribute to pathological conditions, such as cancer and neurodegenerative disorders. The recombinant expression of CAPN7 allows for detailed analysis of its enzymatic properties, substrate specificity, and interactions with cellular partners. By producing CAPN7 in a controlled environment, researchers can investigate its role in health and disease, paving the way for potential therapeutic applications. Understanding CAPN7's function and regulatory mechanisms could lead to novel strategies for treating muscle degeneration, improving muscle regeneration, and developing targeted therapies for diseases associated with dysregulated calpain activity. This line of research not only enhances our knowledge of CAPN7 but also contributes to the broader understanding of calpain biology.
